CROX- Double from here by the end of the year
To consider the potential of this outcome, we can examine a few factors:
Recent Performance and Future Outlook: Crocs recently topped fourth-quarter revenue views and reported an optimistic 2023 outlook with profits exceeding analyst consensus views. The company expects revenue to grow 27%-30% with adjusted EPS of $2.06-$2.19 in Q1 2023, and full-year sales to increase 10%-13% to $3.9 billion-$4.0 billion2. It's worth noting that these figures exceed analysts' predictions of full-year EPS of $10.86 and $3.97 billion in revenue2.
Analyst Ratings and Industry Position: CFRA analyst Zachary Warring recently increased Crocs' stock price target to $150 and maintained a "Strong Buy" rating, indicating a positive outlook. Furthermore, Crocs leads the Apparel-Shoes & Retail Manufacturing industry group, which ranks a strong No. 12 among the 197 industry groups tracked by IBD2.
Technical Analysis: The stock recently bounced off its 200-day moving average, which is a significant long-term support line.
Recent Performance and Future Outlook: Crocs recently topped fourth-quarter revenue views and reported an optimistic 2023 outlook with profits exceeding analyst consensus views. The company expects revenue to grow 27%-30% with adjusted EPS of $2.06-$2.19 in Q1 2023, and full-year sales to increase 10%-13% to $3.9 billion-$4.0 billion2. It's worth noting that these figures exceed analysts' predictions of full-year EPS of $10.86 and $3.97 billion in revenue2.
Analyst Ratings and Industry Position: CFRA analyst Zachary Warring recently increased Crocs' stock price target to $150 and maintained a "Strong Buy" rating, indicating a positive outlook. Furthermore, Crocs leads the Apparel-Shoes & Retail Manufacturing industry group, which ranks a strong No. 12 among the 197 industry groups tracked by IBD2.
Technical Analysis: The stock recently bounced off its 200-day moving average, which is a significant long-term support line.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.